Ep Wealth Advisors, LLC E Ffector Therapeutics, Inc. Transaction History

Ep Wealth Advisors, LLC

  • $9.28 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 22, 2023
BUY
$0.49 - $0.88 $7,846 - $14,092
16,014 Added 106.86%
31,000 $18,000
Q2 2023

Aug 14, 2023
SELL
$0.35 - $1.39 $917 - $3,643
-2,621 Reduced 14.89%
14,986 $12,000
Q1 2023

Jun 05, 2023
BUY
$0.35 - $0.67 $6,162 - $11,796
17,607 New
17,607 $6,000

Others Institutions Holding EFTR

# of Institutions
6
Shares Held
6.53M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Ep Wealth Advisors, LLC Portfolio

Follow Ep Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email